Our community

Who is part of the BioConvS community?

Every lab located in Ile-de-France which works on one of our DIM thematics of synthetic biology, biotherapy and bioproduction is eligible to apply to be part of the DIM. In order to do so, a lab member has to fill in the affiliation form at the link here below. Only labs that have submitted their affiliation form can apply to all our grant calls, trainings and events.

Bioproduction and Biotherapy in Ile-de-France

Cartography of the Bioproduction and Biotherapy sector – credits: Institut Paris Région

BioConvS Perimeter

At launch, CBioConvS harbors a community of 40 laboratories, 70 research groups representing >250researchers, >150 engineers, >300 doctoral students and post-doctoral fellows and XX private sector actors (start-ups and companies)

Governance

ComEx members

Anne Galy (INSERM, Genopole), Harry Sokol (PU-PH, INSERM, Sorbonne Université), Pascal Hersen (DR CNRS, Institut Curie – PSL, Sorbonne Université), Stéphane Lemaire (DR, CNRS, Sorbonne Université), Amanda SILVA BRUN (DR CNRS, Université Paris Cité), Ariel Lindner (INSERM, Université Paris Cité)

The consortium

Partners from universities and research institutes: Université Paris Cité, Sorbonne University, Institut Curie, PSL, Institut Micalis (INRAE), INSERM, Université Paris-Saclay, Genopôle. Valorization partners: Medicen, CNRS Innovation, Inserm Transfert, Erganeo, etc.

Industrial partners: Sanofi, Servier, Eligo Biosciences, Biomemory, etc.

BioconvS is co-headed by:

Amanda Silva Brun – CR CNRS, co-coordinator of the IVEth Platform at Université Paris Cité, Faculty of Sciences, vice-president of the French Society of Nanomedicine (SFNano) and co-founder of the start-ups Everzom and Evora Biosciences.

Contact Amanda Silva Brun

Ariel B. Lindner – DR INSERM, Director of Unit U1284 at Université Paris Cité, Faculty of Sciences, member of CSS1 INSERM, co-founder and Director of Biology for Global Good at the Learning Planet Institute (former Interdisciplinary Research Center – CRI).

Contact Ariel B. Lindner